Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes

Diabetes, Obesity and Metabolism

Volumn 9, Issue 4, 2007, Pages 490-497

  MacLaren, R ^a   Cui, W ^a,b   Cianflone, Katherine ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Adipokines; Metabolic; Obesity visfatin; Syndrome

Indexed keywords

DEXAMETHASONE; INSULIN; MESSENGER RNA; OLEIC ACID; PALMITIC ACID; PROGESTERONE; ROSIGLITAZONE; SEX HORMONE; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; VISFATIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BODY FAT DISTRIBUTION; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HORMONAL REGULATION; LIPID STORAGE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROADIPOCYTE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 34347385041     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00625.x     Document Type: Article

References (35)

1. Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430.
2. Faraj M, Lu HL, Cianflone K. Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 2004; 82: 170-190.
3. Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355.
4. Chae GN, Kwak SJ. NF-kappaB is involved in the TNF-alpha induced inhibition of the differentiation of 3T3-L1 cells by reducing PPARgamma expression. Exp Mol Med 2003; 35: 431-437.
5. McGlothlin JR, Gao L, Lavoie T et al. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet 2005; 43: 127-141.
6. Patrone L, Damore MA, Lee MB, Malone CS, Wall R. Genes expressed during the IFN gamma-induced maturation of pre-B cells. Mol Immunol 2002; 38: 597-606.
7. Hug C, Lodish HF. Medicine. Visfatin: A new adipokine. Science 2005; 307: 366-367.
8. Kloting N, Kloting I. Visfatin: Gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 2005; 332: 1070-1072.
9. Berndt J, Kloting N, Kralisch S et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005; 54: 2911-2916.
10. Gorzelniak K, Janke J, Engeli S, Sharma AM. Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm Metab Res 2001; 33: 625-627.
11. Hauner H, Rohrig K, Petruschke T. Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function. Eur J Clin Invest 1995; 25: 90-96.
12. Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003; 1609: 127-143.
13. Maslowska M, Wang HW, Cianflone K. Novel roles for acylation stimulating protein/C3adesArg: A review of recent in vitro and in vivo evidence. Vitam Horm 2005; 70: 309-332.
14. Lane MD, Reed BC, Clements PR. Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipocytes. Prog Clin Biol Res 1981; 66: 523-542.
15. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003; 27: 875-888.
16. Kralisch S, Klein J, Lossner U et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005; 185: R1-R8.
17. Bjorntorp P. Hormonal control of regional fat distribution. Hum Reprod 1997; 12 (Suppl. 1): 21-25.
18. Takenouchi T, Takayama Y, Takezawa T. Co-treatment with dexamethasone and octanoate induces adipogenesis in 3T3-L1 cells. Cell Biol Int 2004; 28: 209-216.
19. Sethi JK, Vidal-Puig A. Visfatin: The missing link between intra-abdominal obesity and diabetes? Trends Mol Med 2005; 11: 344-347.
20. Iglesias P, Alvarez FP, Codoceo R, Diez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 2003; 59: 621-629.
21. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001; 4: 499-502.
22. Di Carlo C, Tommaselli GA, Nappi C. Effects of sex steroid hormones and menopause on serum leptin concentrations. Gynecol Endocrinol 2002; 16: 479-491.
23. Collison M, Campbell IW, Salt IP et al. Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins. Diabetologia 2000; 43: 1374-1380.
24. Epps-Fung M, Williford J, Wells A, Hardy RW. Fatty acid-induced insulin resistance in adipocytes. Endocrinology 1997; 138: 4338-4345.
25. Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: Evidence for insulin resistance. J Clin Endocrinol Metab 1985; 61: 807-811.
26. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83: 1168-1173.
27. Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su JL, Ringold GM. TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression. Endocrinology 1997; 138: 2776-2783.
28. McGowan KM, Police S, Winslow JB, Pekala PH. Tumor necrosis factor-alpha regulation of glucose transporter (GLUT1) mRNA turnover. Contribution of the 3′-untranslated region of the GLUT1 message. J Biol Chem 1997; 272: 1331-1337.
29. Stephens JM, Carter BZ, Pekala PH, Malter JS. Tumor necrosis factor alpha-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-L1 preadipocytes. Regulation by the adenosine-uridine binding factor. J Biol Chem 1992; 267: 8336-8341.
30. Cornelius P, Marlowe M, Lee MD, Pekala PH. The growth factor-like effects of tumor necrosis factor-alpha. Stimulation of glucose transport activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes. J Biol Chem 1990; 265: 20506-20516.
31. Kralisch S, Klein J, Lossner U et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005; 289: E586-E590.
32. Boden G, Cheung P, Mozzoli M, Fried SK. Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism 2003; 52: 753-759.
33. Shadid S, Jensen MD. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 2003; 26: 3148-3152.
34. Ando H, Yanagihara H, Hayashi Y et al. Rhythmic mRNA expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 2005; 146: 5631-5636.
35. Choi KC, Ryu OH, Lee KW et al. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Biochem Biophys Res Commun 2005; 336: 747-753.